RenovoRx, Inc. - RNXT
About Gravity Analytica
Recent News
- 02.26.2025 - RenovoRx Advances Commercialization of RenovoCath® with Several New Purchase Orders, Including Customer Reorders
- 02.13.2025 - Micro-CT Imaging Following Intra-Arterial Delivery of a Radiopaque Silicone Polymer Using a Double-Balloon Occlusion Catheter in Pigs: A Model to Analyze Tissue Penetration via the Trans-Arterial Micro Perfusion (TAMP) Technique Presented at 2025 Society of Interventional Oncology Annual Conference, February, 2025
- 02.13.2025 - RenovoRx Highlights Promising Pre-Clinical Data Abstract: TAMP™ Therapy Platform Offers Potential to Improve Localized and Targeted Drug Delivery
- 02.13.2025 - RenovoRx Highlights Promising Pre-Clinical Data Abstract: TAMP™ Therapy Platform Offers Potential to Improve Localized and Targeted Drug Delivery
- 02.11.2025 - RenovoRx Announces Closing of $12.1 Million Underwritten Public Offering of Common Stock
- 02.07.2025 - RenovoRx Announces Pricing of $12.1 Million Underwritten Public Offering of Common Stock
- 02.07.2025 - RenovoRx Announces Pricing of $12.1 Million Underwritten Public Offering of Common Stock
- 02.06.2025 - RenovoRx Announces Proposed Public Offering
- 02.06.2025 - RenovoRx Announces Proposed Public Offering
- 02.06.2025 - RenovoRx Announces Proposed Public Offering